{% extends "layout.html" %}

<!-- Header -->
{% block header %}
<header class="py-5 mb-5" id="header" style="background-image: linear-gradient(0deg, rgba(0,0,0,0.65) 0%, rgba(0,0,0,0) 100%),url(https://static.igem.wiki/teams/4214/wiki/safety/safety-header.png);">
  <div class="container h-100">
    <div class="row h-100">
      <div class="col-lg-12">
        <h1 class="display-4 text-white">Safety</h1>
      </div>
    </div>
  </div>
</header>
{% endblock %}

{% block page_content %}

<!-- side bar -->
<div class="row mt-4">
  <div class="col-lg-3">
    <div class="side-bar sticky-top">
      <nav class="navigation">
        <ul class="nav-ul-sidebar">
          <li class="nav-ul-li-sidebar">
            <a class="nav-ul-li-a-sidebar" href="#tag1">Risks in Synthetic Biology / Key Biosecurity Vocabulary</a>
            <a class="nav-ul-li-a-sidebar" href="#tag2">Safeguarding from Synbio Risks</a>
            <a class="nav-ul-li-a-sidebar" href="#tag3">Safety in our project</a>
            <a class="nav-ul-li-a-sidebar" href="#tag4">Safe Lab Work</a>
            <a class="nav-ul-li-a-sidebar" href="#tag5">Safe Project Design</a>
            <a class="nav-ul-li-a-sidebar" href="#references">References</a>

          </li>
        </ul>
      </nav>
    </div>
  </div>
  <!-- END of sidebar -->

  <!-- Include chapters here -->
  <div class="col-lg-9">
    <div class="main-content">

      <section id="tag1">
        <h2>Risks in Synthetic Biology / Key Biosecurity Vocabulary</h2>

        <p>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> A large risk in synthetic biology is technology that can be used for both good and bad — so called dual use. An example of this are vaccines that could also be used as bioweapons. It’s crucial that ethical concerns are considered early in the process. If the downside of the research is too large it might be wise to wait until there is a way to decrease the risk of it falling into the wrong hands. <a href="#references">[1]</a><br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Information hazards are similar to the dual use dilemma. It’s exactly what it sounds like — information which could be used to harm for instance by bioterrorists. The unilateralists curse makes this extra harmful since information in the hands of a bad actor is enough to create harmful effects even though all other actors are using the information responsibly. <a href="#references">[2]</a><br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> GCBRs are biological risks of a massive scale. Imagine a pandemic which wipes out civilization and the future of humanity. With faster development of engineering in synthetic biology, it is not unimaginable that something like this could be created. <a href="#references">[3]</a><br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Bioweapons are weapons made with biology for instance smallpox has been weaponized in the past. <a href="#references">[4]</a> Using bioweapons in war is considered a war crime. <a href="#references">[5]</a><br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Gain-of-function research in biotechnology is about making pathogens more transmissible or more dangerous. <a href="#references">[6]</a> This ties together with information hazard since that information can be used for both good and bad purposes for updating vaccines against new variants of covid or making a bioweapon.<br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Gene drives are genetic elements which make sure that more than half of the offspring inherits certain genes. This has been most debated for malaria mosquitos. There are many ethical implications, especially on ecosystems. <a href="#references">[7]</a><br><br>
        </p>

      </section>

      <section id="tag2">
        <h2 class="revealfromtop">Safeguarding from Synbio Risks</h2>
        <p class="reveal">
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Surveillance of emerging pathogens which could cause new pandemics is important in order to be able to take action, use protective measures to contain the spread and develop vaccines as fast as possible. An example of this is using metagenomics to screen wastewater and look for spikes in new unknown DNA. <a href="#references">[8]</a><br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Vaccine technology is a great tool for protecting people against harmful effects and reaching immunity as quickly as possible. The idea is to give the immune system a small non-harmful piece of the pathogen to practice on so that it doesn’t get sick when exposed to it.<br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Technology design is important to consider in terms of information hazards and dual use. The key is to not create incentives for bad actors, as well as decreasing the ways it can be used for harmful purposes. An example of this would be to screen DNA orders for harmful sequences before synthesizing and selling them. <a href="#references">[9]</a><br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Policy and global cooperation increases the likelihood of standard practices and legislation. Since pathogens don’t understand borders, cooperation is non negotiable for managing outbreaks.<br><br>
          <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Personal protective equipment such as face masks or rubber gloves is a great way to protect yourself and others from both chemicals and potentially harmful toxins or organisms.<br><br>
        </p>
      </section>




      <section id="tag3">
        <h2 class="revealfromtop">Safety in our project</h2>
        <p class="reveal">
          We had two incidents of covid in our team and the affected students chose to stay home to protect others from an infection. Our policy in case of illness indicated to stay at home and recover.
        </p>
        <p class="reveal">
          Depending on what was most safe and suitable, we used open benches, fume hoods or biosafety cabinets. For instance, when handling potential carcinogens such as s-acrylamide, we used personal protective equipment under a fume hood. Our work with <i>E. coli</i> was conducted in a standard microbiological lab with security level one. For the HEK cells, a level two lab was used in order to get moderate containment.
        </p>
        <p class="reveal">
          Since we were working with synthetic organisms with antibiotic resistance genes, we adopted appropriate methods of containment and disposal. These genes could pose a risk for furthering antibiotic resistance in harmful pathogens.
        </p>
      </section>



      <section id="tag4">
        <h2 class="revealfromtop">Safe Lab work</h2>
        <p class="reveal">
          As guidance we used the rules from the universities where we did our lab work: Karolinska Institute and KTH Royal Institute of Technology, as well as The Public Health Agency of Sweden.
        </p>

        <div class="row mt-4">
          <div class="col-6 reveal">
            <h4>Safety and security training about topics:</h4>
            <p>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Lab access and rules<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Responsible individuals<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Differences between biosafety levels<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Biosafety equipment<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Good microbial technique<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Disinfection and sterilization<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Emergency procedures<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Rules for transporting samples between labs or shipping between institutions<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Physical biosecurity<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Personnel biosecurity<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Data biosecurity / cyberbiosecurity<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Chemical, fire and electrical safety<br>
            </p>
          </div>

          <div class="col-6 reveal">
            <h4>Implemented measures:</h4>
            <p>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Accident reporting<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Personal Protective Equipment<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Inventory controls<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Physical access controls<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Data access controls<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Waste management system<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Additional containment<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Project-specific safety or security training<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Consulting with other experts about managing risks<br>
              <svg fill="#326789" width="15" height="15" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Pro 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. --><path d="M470.6 105.4c12.5 12.5 12.5 32.8 0 45.3l-256 256c-12.5 12.5-32.8 12.5-45.3 0l-128-128c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0L192 338.7 425.4 105.4c12.5-12.5 32.8-12.5 45.3 0z"/></svg> Consulting with iGEM about managing risks<br>

            </p>
          </div>
        </div>
      </section>


      <section id="tag5">
        <h2 class="revealfromtop">Safe Project Design</h2>
        <p class="reveal">
          To the best of our knowledge, the parts and organisms were relatively low risk. For the HEK cells which weren’t on the white list, we submitted a check in form. HEK cells belong to risk group two and could potentially be a hazard to immunodeficient individuals since the genome contains Adenovirus 5 DNA. For this we used BSL2 containment, sterile techniques, a special safety introduction from the department expert and supervision. 
        </p>
        <p class="reveal">
          We have not experienced any accidental release from the designated areas. While working, we were mindful of the security training and the implemented measures to minimize such risks. Since we believe our institution is sufficient at managing risks, we did not bring in external risk experts. For future clinical trials of our product, we will contact external experts to assess risks of large scale production of recombinant proteins and concerns related to drug approval. 
        </p>

      </section>


      <section id="references">
        <!-- REFERENCES !!! -->
        <h2 class="revealfromtop">References</h2>
          <div class="tabs reveal">
            <div class="tab">
              <input type="checkbox" id="chck1">
              <label class="tab-label" for="chck1">References</label>
              <div class="tab-content">
                <ol>
                  <li>
                    <p><!--authors here-->A. C. Bhowmik<br>
                    <!--paper titles--><b style="font-weight: bold !important;">Dual-Use in Synthetic Biology: Balancing Intellectual Freedom with Regulations on Research</b><br>
                    <!-- journal's name--><i> Stanford Journal of Public Health, vol. 6, 2017</i><br>
                    <!-- link to artile--><a href="https://ojs.stanford.edu/ojs/index.php/sjph/article/view/1228/1138" target="_blank">Read it</a>
                    </p>
                  <hr>
                  </li>
                  <li>
                    <p><!--authors here-->A. C. Nieuwenweg, B. D. Trump, K. Klasa, D. A. Bleijs, and K. A. Oye<br>
                    <!--paper titles--><b style="font-weight: bold !important;">Emerging Biotechnology and Information Hazards</b><br>
                    <!-- journal's name--><i>NATO Science for Peace and Security Series C: Environmental Security. Springer, pp 131-140, 2021</i><br>
                    <!-- link to artile--><a href="https://doi.org/10.1007/978-94-024-2086-9_9" target="_blank">DOI: 10.1007/978-94-024-2086-9_9</a>
                    </p>
                  <hr>
                  </li>
                
                  <li>
                    <p><!--authors here-->Toby Ord<br>
                    <!--paper titles--><b style="font-weight: bold !important;">The Precipice</b><br>
                    <!-- journal's name--><i>The Precipice</i><br>
                    <!-- link to artile--><a href="#" target="_blank"></a>
                    </p>
                  <hr>
                  </li>   

                  <li>
                    <p><!--authors here-->K. Alibek<br>
                    <!--paper titles--><b style="font-weight: bold !important;">Smallpox: a disease and a weapon</b><br>
                    <!-- journal's name--><i>International Journal of Infectious Diseases, vol. 8, no. 2, pp. 3-8, 2004</i><br>
                    <!-- link to artile--><a href="https://doi.org/10.1016/j.ijid.2004.09.004" target="_blank">DOI: 10.1016/j.ijid.2004.09.004</a>
                    </p>
                  <hr>
                  </li>

                  <li>
                    <p><!--authors here-->J. GoldWat<br>
                    <!--paper titles--><b style="font-weight: bold !important;">The Biological Weapons Convention: An overview</b><br>
                    <!-- journal's name--><i>International Review of the Red Cross (1961 - 1997), vol. 37, no. 318, pp. 251-265, 1997</i><br>
                    <!-- link to artile--><a href="https://www.cambridge.org/core/journals/international-review-of-the-red-cross-1961-1997/article/abs/biological-weapons-convention-an-overview/D926279DB51CB1D66EF77D00786D9A7A" target="_blank">DOI: 10.1017/S0020860400084679</a>
                    </p>
                  <hr>
                  </li>
                  
                  <li>
                    <p><!--authors here-->National Academics Press (US)<br>
                    <!--paper titles--><b style="font-weight: bold !important;">Gain-of-Function Research: Background and Alternatives</b><br>
                    <!-- journal's name--><i>Potential Risks and Benefits of Gain-of-Function Research: Summary of a Workshop, 2015</i><br>
                    <!-- link to artile--><a href="https://www.ncbi.nlm.nih.gov/books/NBK285579/" target="_blank">Read it</a>
                    </p>
                  <hr>
                  </li>
                  
                  <li>
                    <p><!--authors here-->K. L. Warmbrod, A. Kobokovich, R. West, G. Ray, M. Trotochaud, and M. Montague<br>
                    <!--paper titles--><b style="font-weight: bold !important;">New Report from Johns Hopkins Center for Health Security: Gene Drives: Pursuing Opportunities, Minimizing Risk</b><br>
                    <!-- journal's name--><i>Center News, 2020</i><br>
                    <!-- link to artile--><a href="https://www.centerforhealthsecurity.org/news/center-news/2020/2020-05-20-gene-drives-report.html" target="_blank">Read it</a>
                    </p>
                  <hr>
                  </li>
                  
                  <li>
                    <p><!--authors here--> The Nucleic Acid Observatory Consortium<br>
                    <!--paper titles--><b style="font-weight: bold !important;">A Global Nucleic Acid Observatory for Biodefense and Planetary Health</b><br>
                    <!-- journal's name--><i>Cornell University, 2021</i><br>
                    <!-- link to artile--><a href="https://doi.org/10.48550/arXiv.2108.02678" target="_blank">Read it</a>
                    </p>
                  <hr>
                  </li>
                  
                  <li>
                    <p><!--authors here-->C. R. Isaac<br>
                    <!--paper titles--><b style="font-weight: bold !important;">Establishing an incentive-based multistakeholder approach to dual-use DNA screening</b><br>
                    <!-- journal's name--><i>Biochem Cell Biol., vol. 100, no. 3, pp. 268-273, 2022</i><br>
                    <!-- link to artile--><a href="https://pubmed.ncbi.nlm.nih.gov/35290750/" target="_blank">DOI: 10.1139/bcb-2021-0504</a>
                    </p>
                  </li>
                </ol>
              </div>
            </div>  
          </div>
      </section>


      <section>
        <div class="box">
          <a href="{{ url_for('pages', page='implementation') }}" class="a_pages"><div class="reveal flashbox_pages"><p class="p_pages"><svg fill="#FFFFFF" width="20" height="20" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc. --><path d="M9.4 233.4c-12.5 12.5-12.5 32.8 0 45.3l160 160c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3L109.2 288 416 288c17.7 0 32-14.3 32-32s-14.3-32-32-32l-306.7 0L214.6 118.6c12.5-12.5 12.5-32.8 0-45.3s-32.8-12.5-45.3 0l-160 160z"/></svg> Implementation</p></div></a>

          <a href="{{ url_for('pages', page='team') }}" class="a_pages"><div class="reveal flashbox_pages"><p class="p_pages">Team <svg fill="#FFFFFF" width="20" height="20" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.2.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2022 Fonticons, Inc. --><path d="M438.6 278.6c12.5-12.5 12.5-32.8 0-45.3l-160-160c-12.5-12.5-32.8-12.5-45.3 0s-12.5 32.8 0 45.3L338.8 224 32 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l306.7 0L233.4 393.4c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0l160-160z"/></svg></p></div></a>
        </div>
      </section>
    </div>
  </div>
</div>
{% endblock %}
